{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T10:39:02Z","timestamp":1786358342943,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol Phys Technol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12194-025-00960-9","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T17:18:14Z","timestamp":1757092694000},"page":"1143-1151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Margin for compensating displacement of adrenal gland metastasis and fiducial marker along with respiratory phase in real-time motion-tracking radiation therapy"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-7803","authenticated-orcid":false,"given":"Yuki","family":"Aoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Tomida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosei","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"960_CR1","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.rpor.2015.05.009","volume":"20","author":"E Ippolito","year":"2015","unstructured":"Ippolito E, D\u2019Angelillo RM, Fiore M, Molfese E, Trodella L, Ramella S. SBRT: a viable option for treating adrenal gland metastases. Rep Pract Oncol Radiother. 2015;20:484\u201390. https:\/\/doi.org\/10.1016\/j.rpor.2015.05.009.","journal-title":"Rep Pract Oncol Radiother"},{"key":"960_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijrobp.2020.05.062","volume":"110","author":"PK Stumpf","year":"2021","unstructured":"Stumpf PK, Yorke ED, El Naqa I, Cuneo KC, Grimm J, Goodman KA. Modeling of tumor control probability in stereotactic body radiation therapy for adrenal tumors. Int J Radiat Oncol Biol Phys. 2021;110:217\u201326. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.05.062.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"960_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/ijc.34017","volume":"151","author":"D Buergy","year":"2022","unstructured":"Buergy D, W\u00fcrschmidt F, Gkika E, H\u00f6rner-Rieber J, Knippen S, Gerum S, et al. Stereotactic body radiotherapy of adrenal metastases-a dose-finding study. Int J Cancer. 2022;151:412\u201321. https:\/\/doi.org\/10.1002\/ijc.34017.","journal-title":"Int J Cancer"},{"key":"960_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13014-020-1480-0","volume":"15","author":"L K\u00f6nig","year":"2020","unstructured":"K\u00f6nig L, H\u00e4fner MF, Katayama S, Koerber SA, Tonndorf-Martini E, Bernhardt D, et al. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients. Radiat Oncol. 2020;15:30. https:\/\/doi.org\/10.1186\/s13014-020-1480-0.","journal-title":"Radiat Oncol"},{"key":"960_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10585-020-10052-0","volume":"37","author":"CA Helis","year":"2020","unstructured":"Helis CA, Hughes RT, Nieto K, Ufondu A, Daugherty EC, Farris MK. Adrenal SBRT: a multi-institutional review of treatment outcomes and toxicity. Clin Exp Metastasis. 2020;37:585\u201392. https:\/\/doi.org\/10.1007\/s10585-020-10052-0.","journal-title":"Clin Exp Metastasis"},{"key":"960_CR6","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.adro.2017.07.011","volume":"2","author":"K Plichta","year":"2017","unstructured":"Plichta K, Camden N, Furqan M, Hejleh TA, Clamon GH, Zhang J, et al. SBRT to adrenal metastases provides high local control with minimal toxicity. Adv Radiat Oncol. 2017;2:581\u20137. https:\/\/doi.org\/10.1016\/j.adro.2017.07.011.","journal-title":"Adv Radiat Oncol"},{"key":"960_CR7","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejmp.2017.05.045","volume":"38","author":"B Chen","year":"2017","unstructured":"Chen B, Hu Y, Liu J, Cao AN, Ye LX, Zeng ZC. Respiratory motion of adrenal gland metastases: analyses using four-dimensional computed tomography images. Phys Med. 2017;38:54\u20138. https:\/\/doi.org\/10.1016\/j.ejmp.2017.05.045.","journal-title":"Phys Med"},{"key":"960_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tipsro.2019.11.007","volume":"12","author":"M de Kuijer","year":"2019","unstructured":"de Kuijer M, van Egmond J, Kouwenhoven E, Bruijn-Krist D, Ceha H, Mast M. Breath-hold versus mid-ventilation in SBRT of adrenal metastases. Tech Innov Patient Support Radiat Oncol. 2019;12:23\u20137. https:\/\/doi.org\/10.1016\/j.tipsro.2019.11.007.","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"960_CR9","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.clon.2020.09.008","volume":"32","author":"J Dhont","year":"2020","unstructured":"Dhont J, Harden SV, Chee LYS, Aitken K, Hanna GG, Bertholet J. Image-guided radiotherapy to manage respiratory motion: lung and liver. Clin Oncol (R Coll Radiol). 2020;32:792\u2013804. https:\/\/doi.org\/10.1016\/j.clon.2020.09.008.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"960_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phro.2022.12.002","volume":"25","author":"Y Tanabe","year":"2022","unstructured":"Tanabe Y, Kiritani M, Deguchi T, Hira N, Tomimoto S. Patient-specific respiratory motion management using lung tumors vs fiducial markers for real-time tumor-tracking stereotactic body radiotherapy. Phys Imaging Radiat Oncol. 2022;25:100405. https:\/\/doi.org\/10.1016\/j.phro.2022.12.002.","journal-title":"Phys Imaging Radiat Oncol"},{"key":"960_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2021.07.020","volume":"163","author":"N Hoekstra","year":"2021","unstructured":"Hoekstra N, Habraken S, Swaak-Kragten A, Pignol JP, Hoogeman M. Fiducial marker motion relative to the tumor bed has a significant impact on PTV margins in partial breast irradiation. Radiother Oncol. 2021;163:1\u20136. https:\/\/doi.org\/10.1016\/j.radonc.2021.07.020.","journal-title":"Radiother Oncol"},{"key":"960_CR12","doi-asserted-by":"publisher","first-page":"1021119","DOI":"10.3389\/fonc.2022.1021119","volume":"12","author":"X Sun","year":"2022","unstructured":"Sun X, Dai Z, Xu M, Guo X, Su H, Li Y. Quantifying 6D tumor motion and calculating PTV margins during liver stereotactic radiotherapy with fiducial tracking. Front Oncol. 2022;12:1021119. https:\/\/doi.org\/10.3389\/fonc.2022.1021119.","journal-title":"Front Oncol"},{"key":"960_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.5603\/RPOR.a2022.0089","volume":"27","author":"Y Nitta","year":"2022","unstructured":"Nitta Y, Ueda Y, Murata S, Isono M, Ohira S, Masaoka A, et al. Setup accuracy and dose attenuation of a wooden immobilization system for lung stereotactic body radiotherapy. Rep Pract Oncol Radiother. 2022;27:809\u201320. https:\/\/doi.org\/10.5603\/RPOR.a2022.0089.","journal-title":"Rep Pract Oncol Radiother"},{"key":"960_CR14","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1002\/mp.14788","volume":"48","author":"N Hardcastle","year":"2021","unstructured":"Hardcastle N, Briggs A, Caillet V, et al. Quantification of the geometric uncertainty when using implanted markers as a surrogate for lung tumor motion. Med Phys. 2021;48:2724\u201332. https:\/\/doi.org\/10.1002\/mp.14788.","journal-title":"Med Phys"},{"key":"960_CR15","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1088\/0031-9155\/56\/17\/001","volume":"56","author":"Y Seppenwoolde","year":"2011","unstructured":"Seppenwoolde Y, Wunderink W, Wunderink-van Veen SR, Storchi P, M\u00e9ndez Romero A, Heijmen BJ. Treatment precision of image-guided liver SBRT using implanted fiducial markers depends on marker-tumour distance. Phys Med Biol. 2011;56:5445\u201368. https:\/\/doi.org\/10.1088\/0031-9155\/56\/17\/001.","journal-title":"Phys Med Biol"},{"key":"960_CR16","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1002\/mp.13819","volume":"46","author":"Y Akdeniz","year":"2019","unstructured":"Akdeniz Y, Yegingil I, Yegingil Z. Effects of metal implants and a metal artifact reduction tool on calculation accuracy of AAA and Acuros XB algorithms in small fields. Med Phys. 2019;46:5326\u201335. https:\/\/doi.org\/10.1002\/mp.13819.","journal-title":"Med Phys"},{"key":"960_CR17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.5603\/RPOR.a2022.0098","volume":"27","author":"A Gnanasambandam","year":"2022","unstructured":"Gnanasambandam A, Raj NAN, K S. Effects of metal implants and validation of four treatment planning methods used for radiotherapy dose calculation. Rep Pract Oncol Radiother. 2022;27:821\u201331. https:\/\/doi.org\/10.5603\/RPOR.a2022.0098.","journal-title":"Rep Pract Oncol Radiother"},{"key":"960_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1378\/chest.102.1.313","volume":"102","author":"N Voravud","year":"1992","unstructured":"Voravud N, Shin DM, Dekmezian RH, Dimery I, Lee JS, Hong WK. Implantation metastasis of carcinoma after percutaneous fine-needle aspiration biopsy. Chest. 1992;102:313\u20135. https:\/\/doi.org\/10.1378\/chest.102.1.313.","journal-title":"Chest"},{"key":"960_CR19","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/dc.23137","volume":"42","author":"R Tyagi","year":"2014","unstructured":"Tyagi R, Dey P. Needle tract seeding: an avoidable complication. Diagn Cytopathol. 2014;42:636\u201340. https:\/\/doi.org\/10.1002\/dc.23137.","journal-title":"Diagn Cytopathol"},{"key":"960_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.ctrv.2007.04.001","volume":"33","author":"R Stigliano","year":"2007","unstructured":"Stigliano R, Marelli L, Yu D, Davies N, Patch D, Burroughs AK. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev. 2007;33:437\u201347. https:\/\/doi.org\/10.1016\/j.ctrv.2007.04.001.","journal-title":"Cancer Treat Rev"},{"key":"960_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.lungcan.2007.03.020","volume":"57","author":"C Greco","year":"2007","unstructured":"Greco C, Rosenzweig K, Cascini GL, Tamburrini O. Current status of PET\/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC). Lung Cancer. 2007;57:125\u201334. https:\/\/doi.org\/10.1016\/j.lungcan.2007.03.020.","journal-title":"Lung Cancer"},{"key":"960_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.817413","volume":"12","author":"F Li","year":"2022","unstructured":"Li F, Li Y, Wang X, Zhang Y, Liu X, Liu S, et al. Inter-observer and intra-observer variability in gross tumor volume delineation of primary esophageal carcinomas based on different combinations of diagnostic multimodal images. Front Oncol. 2022;12:817413. https:\/\/doi.org\/10.3389\/fonc.2022.817413.","journal-title":"Front Oncol"},{"key":"960_CR23","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13014-020-01691-4","volume":"16","author":"X Chang","year":"2021","unstructured":"Chang X, Deng W, Wang X, Zhou Z, Yang J, Guo W, et al. Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China. Radiat Oncol. 2021;16:102. https:\/\/doi.org\/10.1186\/s13014-020-01691-4.","journal-title":"Radiat Oncol"},{"key":"960_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/1754-9485.12462","volume":"60","author":"SK Vinod","year":"2016","unstructured":"Vinod SK, Min M, Jameson MG, Holloway LC. A review of interventions to reduce inter-observer variability in volume delineation in radiation oncology. J Med Imaging Radiat Oncol. 2016;60:393\u2013406. https:\/\/doi.org\/10.1111\/1754-9485.12462.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"960_CR25","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.canrad.2011.03.006","volume":"15","author":"D Roberge","year":"2011","unstructured":"Roberge D, Skamene T, Turcotte RE, Powell T, Saran N, Freeman C. Inter- and intra-observer variation in soft-tissue sarcoma target definition. Cancer Radiother. 2011;15:421\u20135. https:\/\/doi.org\/10.1016\/j.canrad.2011.03.006.","journal-title":"Cancer Radiother"},{"issue":"1","key":"960_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijrobp.2014.09.004","volume":"91","author":"JP Kirkpatrick","year":"2015","unstructured":"Kirkpatrick JP, Wang Z, Sampson JH, McSherry F, Herndon JE, Allen KJ, et al. Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial. Int J Radiat Oncol Biol Phys. 2015;91(1):100\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.09.004.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"960_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijrobp.2020.10.039","volume":"110","author":"J Grimm","year":"2021","unstructured":"Grimm J, Marks LB, Jackson A, Kavanagh BD, Xue J, Yorke E. High dose per fraction, hypofractionated treatment effects in the clinic (HyTEC): an overview. Int J Radiat Oncol Biol Phys. 2021;110:1\u201310. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.10.039.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"960_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.radonc.2019.02.019","volume":"135","author":"E Steiner","year":"2019","unstructured":"Steiner E, Shieh CC, Caillet V, Booth J, O\u2019Brien R, Briggs A, et al. Both four-dimensional computed tomography and four-dimensional cone beam computed tomography under-predict lung target motion during radiotherapy. Radiother Oncol. 2019;135:65\u201373. https:\/\/doi.org\/10.1016\/j.radonc.2019.02.019.","journal-title":"Radiother Oncol"},{"key":"960_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12194-023-00757-8","volume":"17","author":"D Fujimoto","year":"2024","unstructured":"Fujimoto D, Takatsu J, Hara N, Oshima M, Tomihara J, Segawa E, et al. Dosimetric comparison of four-dimensional computed tomography based internal target volume against variations in respiratory motion during treatment between volumetric modulated arc therapy and three-dimensional conformal radiotherapy in lung stereotactic body radiotherapy. Radiol Phys Technol. 2024;17:143\u201352. https:\/\/doi.org\/10.1007\/s12194-023-00757-8.","journal-title":"Radiol Phys Technol"},{"key":"960_CR30","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/acm2.13041","volume":"21","author":"M Dumas","year":"2020","unstructured":"Dumas M, Laugeman E, Sevak P, Snyder KC, Mao W, Chetty IJ, et al. Technical note: comparison of the internal target volume (ITV) contours and dose calculations on 4DCT, average CBCT, and 4DCBCT imaging for lung stereotactic body radiation therapy (SBRT). J Appl Clin Med Phys. 2020;21:288\u201394. https:\/\/doi.org\/10.1002\/acm2.13041.","journal-title":"J Appl Clin Med Phys"},{"key":"960_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13014-016-0724-5","volume":"11","author":"Y Li","year":"2016","unstructured":"Li Y, Ma JL, Chen X, Tang FW, Zhang XZ. 4DCT and CBCT based PTV margin in stereotactic body radiotherapy(SBRT) of non-small cell lung tumor adhered to chest wall or diaphragm. Radiat Oncol. 2016;11:152. https:\/\/doi.org\/10.1186\/s13014-016-0724-5.","journal-title":"Radiat Oncol"},{"key":"960_CR32","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ijrobp.2018.04.056","volume":"102","author":"E Steiner","year":"2018","unstructured":"Steiner E, Shieh CC, Caillet V, Booth J, Hardcastle N, Briggs A, et al. 4-dimensional cone beam computed tomography-measured target motion underrepresents actual motion. Int J Radiat Oncol Biol Phys. 2018;102:932\u201340. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.04.056.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiological Physics and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00960-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12194-025-00960-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12194-025-00960-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T14:11:05Z","timestamp":1763561465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12194-025-00960-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["960"],"URL":"https:\/\/doi.org\/10.1007\/s12194-025-00960-9","relation":{},"ISSN":["1865-0333","1865-0341"],"issn-type":[{"value":"1865-0333","type":"print"},{"value":"1865-0341","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Review Board of Shizuoka Cancer Center (approval number: J2024-9-2024-1). Patient consent was given in the form of an open document.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}